Marina Kropp, MD
Physical Medicine & Rehabilitation · Mequon, WINPI 1255512141
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 35.4% of the total.
Across 31 payments — averaging $11.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$131
- Supernus Pharmaceuticals, Inc.$51
- Novartis$48
- AstraZeneca$28
- Lilly USA, LLC$22
- Bausch Health US, LLC$19
- plus $70 from 4 others
What the payments were for
- Food & beverage$34594%
- Education$246%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 18 | $131 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Novartis | 2 | $48 |
| AstraZeneca | 2 | $28 |
| Lilly USA, LLC | 1 | $22 |
| Bausch Health US, LLC | 1 | $19 |
| Biodelivery Sciences International, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| Pfizer | 1 | $13 |
How this compares
$369 in reported general payments places this provider in the 70th percentile of 207 physical medicine & rehabilitation providers in Wisconsin.
See all physical medicine & rehabilitation providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 14 | $91 |
| Atorvastatin Calcium | 14 | $47 |
| Amlodipine Besylate | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Mequon
- Nicholas KetchumMilwaukee$573K
- Christopher CronsellMilwaukee$353K
- Karin GoodfriendMilwaukee$191K
- John McGuireMilwaukee$75K
- Erin McGonigleMilwaukee$66K
- Noelle LiskaMilwaukee$13K
- Trinh TruongMilwaukee$11K
- Bindiya ShahMilwaukee$10K
- Michelle FaullMonroe$7K
- Allison Glinka PrzybyszMadison$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.